Search research articles
Contact Us
Filters
Showing results (71-80 of 420) with videos related to
Page
of 42
Sort By:
The New England Journal of Medicine
|
July 2, 2015
CLINICAL PROBLEM-SOLVING. A Man with Fever, Cough, and Rash
Bram J Geller, Richard M Stone, Joseph F Merola, et al.
The New England Journal of Medicine
|
November 6, 2024
Two Sides to the Story
Cody E Cotner, Richard M Stone, Amy C Sherman, et al.
Current Cancer Drug Targets
|
August 3, 2013
Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target?
Sophia Adamia, Patrick M Pilarski, Michal Bar-Natan, et al.
Leukemia Research Reports
|
December 24, 2019
Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration
Mary Nauffal, Lillian Werner, Jian Ni, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 17, 2018
Single 6-mg dose of rasburicase: The experience in a large academic medical center
Mary Nauffal, Robert Redd, Jian Ni, et al.
Leukemia Research
|
February 9, 2010
Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients
Gregory A Abel, Carla M Van Bennekom, Richard M Stone, et al.
Experimental Hematology & Oncology
|
October 13, 2015
Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing
Diana Mandelker, Paola Dal Cin, Heather A Jacene, et al.
Leukemia Research
|
January 3, 2015
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes
Daniel A Roberts, Martha Wadleigh, Anne M McDonnell, et al.
American Journal of Hematology
|
August 30, 2008
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission
Richard M Stone, Daniel J DeAngelo, Anna Janosova, et al.
International Journal of Oncology
|
April 6, 2006
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples
Wendy Stock, Daohai Yu, Ted Karrison, et al.
Page
of 42
Search research articles
Search
Showing results (71-80 of 420) with videos related to
Sort By:
Page
of 42
The New England Journal of Medicine
|
July 2, 2015
CLINICAL PROBLEM-SOLVING. A Man with Fever, Cough, and Rash
Bram J Geller, Richard M Stone, Joseph F Merola, et al.
The New England Journal of Medicine
|
November 6, 2024
Two Sides to the Story
Cody E Cotner, Richard M Stone, Amy C Sherman, et al.
Current Cancer Drug Targets
|
August 3, 2013
Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target?
Sophia Adamia, Patrick M Pilarski, Michal Bar-Natan, et al.
Leukemia Research Reports
|
December 24, 2019
Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration
Mary Nauffal, Lillian Werner, Jian Ni, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 17, 2018
Single 6-mg dose of rasburicase: The experience in a large academic medical center
Mary Nauffal, Robert Redd, Jian Ni, et al.
Leukemia Research
|
February 9, 2010
Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients
Gregory A Abel, Carla M Van Bennekom, Richard M Stone, et al.
Experimental Hematology & Oncology
|
October 13, 2015
Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing
Diana Mandelker, Paola Dal Cin, Heather A Jacene, et al.
Leukemia Research
|
January 3, 2015
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes
Daniel A Roberts, Martha Wadleigh, Anne M McDonnell, et al.
American Journal of Hematology
|
August 30, 2008
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission
Richard M Stone, Daniel J DeAngelo, Anna Janosova, et al.
International Journal of Oncology
|
April 6, 2006
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples
Wendy Stock, Daohai Yu, Ted Karrison, et al.
Page
of 42